triazoles has been researched along with Cognition Disorders in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, SJ; Cai, XH; Chen, JY; Fang, L; Gyabaah, AT; Hong, FF; Hu, SY; Li, XC; Li, YA; Li, ZL; Ma, CY; Shao, GH; Tu, YJ; Ying, HY; Yu, CY; Zhang, ZL | 1 |
| Bertrand, E; Boiaryna, L; Buron, F; Chalon, S; Chartier, A; Deloye, JB; Guilloteau, D; Gulhan, Z; Mothes, C; Ouach, A; Page, G; Percina, N; Pin, F; Rodrigues, N; Routier, S; Serriere, S; Suzenet, F; Tangpong, P; Vercouillie, J | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Pintana, H | 1 |
| Bruce, SS; Connolly, ES; Heyer, EJ; Mergeche, JL | 1 |
| Ahmed, RS; Arora, VK; Banerjee, BD; Jain, S; Mediratta, PK | 1 |
| Acosta, JI; Alderete, TJ; Bimonte-Nelson, HA; Camp, BW; Demers, LM; Koebele, SV; Mennenga, SE; Mousa, AA; Tsang, CW | 1 |
| Alberch, J; Canas, PM; Cunha, RA; Delgado-García, JM; Gruart, A; Pérez-Navarro, E; Pliassova, A; Saavedra, A; Tyebji, S | 1 |
| Agostinho, P; Augusto, E; Boison, D; Chen, JF; Cunha, RA; Matos, M; Shen, HY; Wang, Y; Wang, YT; Wei, CJ | 1 |
| Ahrendt, GM; Bender, CM; Berga, SL; Brufsky, AM; Casillo, FE; Dailey, MM; Erickson, KI; Gentry, AL; Kratofil, FM; McAuliffe, PF; Merriman, JD; Rosenzweig, MQ; Ryan, CM; Sereika, SM | 1 |
| Bonneterre, J; Delbeuck, X; Kramar, A; Le Rhun, E; Lefeuvre-Plesse, C; Pasquier, F; Skrobala, E | 1 |
| Hayama, T; Kamata, M; Kondo, S; Maeda, R; Murakami, K; Watanabe, T | 1 |
| Bielajew, C; Collins, B; Mackenzie, J; Stewart, A; Verma, S | 1 |
| Ackerman, Z; Avraham, Y; Berry, EM; Magen, I; Mechoulam, R; Vorobiev, L | 1 |
| Ballard, TM; Buettelmann, B; Fischer, H; Gasser, R; Hernandez, MC; Knoflach, F; Knust, H; Stadler, H; Thomas, AW; Trube, G | 1 |
| Achermann, G; Ballard, T; Buettelmann, B; Fischer, H; Gasser, R; Hernandez, MC; Knoflach, F; Knust, H; Koblet, A; Stadler, H; Thomas, AW; Trube, G; Waldmeier, P | 1 |
| Crossley, M; Lejbak, L; Vrbancic, M | 1 |
| Agrawal, K; Mortimer, JE; Onami, S; Pal, SK | 1 |
| Ball, MP; Barch, DM; Buchanan, RW; Csernansky, JG; Goff, DC; Gold, JM; Green, MF; Jarskog, LF; Javitt, DC; Keefe, RS; Kern, RS; Kimhy, D; Kraus, MS; Lieberman, JA; Marder, SR; McEvoy, JP; McMahon, RP; Mesholam-Gately, RI; Robinson, J; Seidman, LJ | 1 |
| Braudeau, J; Dauphinot, L; de Chaumont, F; Delatour, B; Dodd, RH; Duchon, A; Hérault, Y; Olivo-Marin, JC; Pereira, PL; Potier, MC | 1 |
| Aota, M; Doihara, H; Harada, K; Matsuoka, N; Morita, M; Nakato, K; Ni, K; Saita, K; Sato, Y; Takahashi, S; Yamaji, T; Yamazaki, M; Yarimizu, J | 1 |
| Gil, C; Lipina, TV; Martinez, A; Palomo, V; Roder, JC | 1 |
| Engin, E; Liu, J; Rudolph, U | 1 |
| Fallowfield, L; Howell, T; Jenkins, V; Shilling, V | 1 |
| Fallowfield, L; Howell, A; Hutton, S; Jenkins, V; Shilling, V | 1 |
| Cunha, RA; Dall'Igna, OP; Fett, P; Gomes, MW; Lara, DR; Souza, DO | 1 |
| Imhof, A; Schaer, DJ; Schanz, U; Schwarz, U | 1 |
| Aldenkamp, AP | 1 |
1 review(s) available for triazoles and Cognition Disorders
| Article | Year |
|---|---|
α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.
Topics: Alcoholism; Animals; Anxiety; Central Nervous System Diseases; Chronic Pain; Cognition Disorders; Depression; GABA-A Receptor Agonists; Humans; Polymorphism, Genetic; Pyridazines; Receptors, GABA-A; Schizophrenia; Substance-Related Disorders; Triazoles | 2012 |
3 trial(s) available for triazoles and Cognition Disorders
| Article | Year |
|---|---|
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Female; Humans; Letrozole; Memory; Middle Aged; Nitriles; Postmenopause; Psychomotor Performance; Quality of Life; Tamoxifen; Triazoles | 2015 |
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia.
Topics: Adolescent; Adult; Cognition; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; GABA Agonists; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Pyridazines; Receptors, GABA-A; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Triazoles; Young Adult | 2011 |
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Cognition Disorders; Depression; England; Estrogens; Female; Humans; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nitriles; Personality Inventory; Pilot Projects; Reaction Time; Self-Assessment; Tamoxifen; Triazoles; Verbal Learning | 2004 |
23 other study(ies) available for triazoles and Cognition Disorders
| Article | Year |
|---|---|
Blockade of adenosine A
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain-Derived Neurotrophic Factor; Caspase 3; Chronic Disease; Cognition Disorders; Cognitive Dysfunction; Hippocampus; Hypoxia, Brain; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Pyrimidines; Receptor, Adenosine A2A; Triazoles | 2022 |
Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Cell Survival; Cognition Disorders; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Isotope Labeling; Ligands; Molecular Structure; Nicotinic Agonists; Positron-Emission Tomography; Quinuclidines; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2019 |
DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats.
Topics: Adamantane; Animals; Behavior, Animal; Brain; Cognition Disorders; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Hippocampus; Insulin Resistance; Male; Maze Learning; Memory; Memory Disorders; Mitochondria; Nitriles; Obesity; Oxidative Stress; Pyrazines; Pyrrolidines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hypoglycemic Agents; Inflammation; Logistic Models; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2013 |
Possible role of oxidative stress and brain derived neurotrophic factor in triazophos induced cognitive impairment in rats.
Topics: Animals; Avoidance Learning; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Glutathione; Hippocampus; Insecticides; Male; Malondialdehyde; Maze Learning; Memory; Organothiophosphates; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Triazoles | 2013 |
Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.
Topics: Anastrozole; Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Brain; Cognition Disorders; Estrone; Female; Flutamide; Maze Learning; Menopause; Nitriles; Ovariectomy; Rats, Inbred F344; Receptors, Androgen; Triazoles; Uterus | 2015 |
Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
Topics: Adenosine A2 Receptor Antagonists; Animals; Benzazepines; Cognition Disorders; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine Antagonists; Hippocampus; Huntington Disease; Long-Term Potentiation; Male; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Motor Activity; Pyrimidines; Receptor, Adenosine A2A; Receptors, Dopamine D1; Triazoles | 2015 |
Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Topics: Animals; Astrocytes; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Homeostasis; Kainic Acid; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Psychomotor Disorders; Pyrimidines; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptosomes; Time Factors; Triazoles | 2015 |
Patterns of change in cognitive function with anastrozole therapy.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Educational Status; Female; Humans; Longitudinal Studies; Memory; Middle Aged; Nitriles; Postmenopause; Triazoles | 2015 |
Single administration of a novel γ-secretase modulator ameliorates cognitive dysfunction in aged C57BL/6J mice.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Cognition; Cognition Disorders; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuronal Plasticity; Neuroprotective Agents; Patch-Clamp Techniques; Pyridines; Triazoles | 2016 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Female; Follow-Up Studies; Humans; Mental Recall; Middle Aged; Neoplasms, Hormone-Dependent; Neuropsychological Tests; Nitriles; Prospective Studies; Psychometrics; Reaction Time; Receptors, Estrogen; Tamoxifen; Triazoles | 2009 |
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
Topics: Adenosine A2 Receptor Antagonists; Animals; Bile Ducts; Brain-Derived Neurotrophic Factor; Cannabidiol; Chronic Disease; Cognition; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Female; Gait Disorders, Neurologic; Hepatic Encephalopathy; Ligation; Liver Diseases; Mice; Mice, Inbred Strains; Motor Activity; Receptor, Adenosine A2A; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Treatment Outcome; Triazines; Triazoles | 2009 |
Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.
Topics: Adjuvants, Anesthesia; Animals; Anticonvulsants; Benzodiazepines; Cell Line; Cognition Disorders; Drug Inverse Agonism; GABA-A Receptor Agonists; Humans; Memory, Short-Term; Microsomes, Liver; Rats; Receptors, GABA-A; Scopolamine; Structure-Activity Relationship; Triazoles | 2009 |
The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.
Topics: Animals; Anticonvulsants; Benzodiazepines; Cell Line; Cognition Disorders; Disease Models, Animal; Drug Discovery; Drug Inverse Agonism; GABA-A Receptor Agonists; Humans; Imidazoles; Mice; Protein Binding; Rats; Receptors, GABA-A; Seizures; Structure-Activity Relationship; Triazoles | 2009 |
Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
Topics: Aged; Anastrozole; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Estrogen Antagonists; Fatigue; Female; Humans; Memory Disorders; Middle Aged; Mood Disorders; Neuropsychological Tests; Nitriles; Postmenopause; Statistics, Nonparametric; Surveys and Questionnaires; Tamoxifen; Triazoles | 2010 |
Cognitive changes associated with endocrine therapy for breast cancer.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Female; Humans; Letrozole; Memory; Neoplasms, Hormone-Dependent; Nitriles; Prospective Studies; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; United States; Women's Health | 2010 |
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice.
Topics: Animals; Brain; Cognition Disorders; Disease Models, Animal; Down Syndrome; Drug Delivery Systems; Drug Inverse Agonism; GABA-A Receptor Agonists; Male; Maze Learning; Memory; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Phthalazines; Receptors, GABA-A; Triazoles | 2011 |
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Animals; Brain; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Glycine Plasma Membrane Transport Proteins; Humans; Inhibitory Concentration 50; Male; Memory Disorders; Mice; Oxadiazoles; Permeability; Rats; Rats, Wistar; Schizophrenia; Triazoles | 2012 |
Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cognition Disorders; Cyclic Nucleotide Phosphodiesterases, Type 7; Dose-Response Relationship, Drug; Drugs, Investigational; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Male; Memory; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Neural Inhibition; Nootropic Agents; Phosphodiesterase Inhibitors; Quinazolines; Schizophrenia; Spatial Behavior; Triazoles | 2013 |
The effects of hormone therapy on cognition in breast cancer.
Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cognition; Cognition Disorders; Enzyme Inhibitors; Female; Humans; Memory; Middle Aged; Nitriles; Pilot Projects; Psychometrics; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2003 |
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caffeine; Cognition Disorders; Disease Models, Animal; Drug Synergism; Male; Maze Learning; Mice; Neuroprotective Agents; Peptide Fragments; Phosphodiesterase Inhibitors; Pyrimidines; Receptor, Adenosine A2A; Treatment Outcome; Triazoles | 2007 |
Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Asthenia; Cognition Disorders; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hallucinations; Humans; Irritable Mood; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Triazoles; Vision Disorders; Voriconazole | 2006 |
Effects of antiepileptic drugs on cognition.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; Triazoles; Vigabatrin | 2001 |